title: Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
abstract: Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal (GI) tract characterized by pain or discomfort from the lower abdominal region, which is associated with altered bowel habit. Despite its prevalence, there is currently a lack of effective treatment options for patients. IBS has long been considered as a neurological condition resulting from alterations in the brain gut axis, but immunological alterations are increasingly reported in IBS patients, consistent with the hypothesis that there is a chronic, but low-grade, immune activation. Mediators released by immune cells act to either dampen or amplify the activity of GI nerves. Release of a number of these mediators correlates with symptoms of IBS, highlighting the importance of interactions between the immune and the nervous systems. Investigation of the role of microbiota in these interactions is in its early stages, but may provide many answers regarding the mechanisms underlying activation of the immune system in IBS. Identifying what the key changes in the GI immune system are in IBS and how these changes modulate viscerosensory nervous function is essential for the development of novel therapies for the underlying disorder.
authors: University of Adelaide, Adelaide, South Australia, Australia. patrick.hughes@adelaide.edu.au
authors: Patrick A
authors: PA
authors: Hughes
authors: Heddy
authors: H
authors: Zola
authors: Irmeli A
authors: IA
authors: Penttila
authors: L Ashley
authors: LA
authors: Blackshaw
authors: Jane M
authors: JM
authors: Andrews
authors: Doreen
authors: D
authors: Krumbiegel
mesh_terms: D056704:Adaptive Immunity; D000938:Antigen-Presenting Cells / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D003106:Colon / Q000294:innervation*; D041981:Gastrointestinal Tract / Q000382:microbiology; D006801:Humans; D007113:Immunity, Innate; D043183:Irritable Bowel Syndrome / Q000276:immunology* / Q000382:microbiology; D008407:Mast Cells / Q000276:immunology; D054892:Metagenome; D015213:Neuroimmunomodulation; D013601:T-Lymphocytes / Q000276:immunology